SCHEMBL10464271

SCHEMBL10464271

CCNc1nc(CO)cs1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.46
MAPT P10636 4/20 0.46
MEN1 O00255 4/20 0.46
ALDH1A1 P00352 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
LMNA P02545 1/20 0.46
ALOX15 P16050 1/20 0.46
ALOX12 P18054 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.43
NPSR1 Q6W5P4 1/20 0.43
STAT1 P42224 1/20 0.41
SCD O00767 4/20 0.39
ROCK2 O75116 1/20 0.38
PIM1 P11309 1/20 0.38
GSK3B P49841 1/20 0.38
AURKB Q96GD4 1/20 0.38
HTT P42858 2/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7172668 0.85 MAPT (0.44) KMT2AMAPTMEN1ALDH1A1NPC1
SCHEMBL2612388 0.84 KMT2A (0.49) KMT2AMAPTMEN1ALDH1A1NPC1
SCHEMBL11991767 0.82 MAPT (0.47) KMT2AMAPTMEN1ALDH1A1NPC1
SCHEMBL21917390 0.80
SCHEMBL10466181 0.80 NPC1 (0.54) KMT2AMAPTALDH1A1NPC1RAB9A
SCHEMBL10067956 0.79 GAA (0.55) KMT2AMAPTMEN1ALDH1A1NPC1
SCHEMBL9382083 0.78 AOC3 (0.48) KMT2AMAPTMEN1ALDH1A1NPC1
SCHEMBL15080346 0.78 MAPT (0.44) KMT2AMAPTMEN1ALDH1A1NPC1
SCHEMBL11991383 0.78 MAPT (0.44) KMT2AMAPTMEN1ALDH1A1NPC1
SCHEMBL10466126 0.77 MAPT (0.50) KMT2AMAPTMEN1ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4933355-A ALDOSE REDUCTASE INHIBITORS SANKYO COMPANY LIMITED (JP) 1990-06-12 US disclosed
EP-0337819-A1 Thiazole derivatives, their preparation and their use in the treatment of diabetes complications Sankyo Company Limited (JP) 1989-10-18 EP disclosed